UBC’s Faculty of Pharmaceutical Sciences is where great minds make a difference. The Faculty of Pharmaceutical Sciences at UBC enjoys an international reputation for outstanding pharmaceutical sciences research. Across a broad base of collaborative, paradigm-shaping pilot projects, our world-leading researchers generate relevant results that address the pressing health needs of society. In short, our work improves lives.

Quality learning. Effective communication. Collaboration. Partnership. All this, plus a commitment to practical research discovery is what we're about at UBC Pharm Sci. Through our strong and ever-growing research capabilities, we are transforming the future of health care for the benefit of all.

We're tackling diseases like asthma, diabetes, cancer, heart disease, arthritis and HIV/AIDS. We're developing better ways to deliver drugs and prevent adverse drug reactions. And we're conducting clinical and economic research in pharmaceutical outcomes. 

Our reputation as a top research centre attracts some of the brightest and most productive minds in the field. Our faculty has included a Canadian Diabetes Research Scholar, four Canada Research Chairs, five Michael Smith Foundation Scholars, and three Distinguished University Scholars.

We advance knowledge, health outcomes and the profession of pharmacy leading to enhanced societal benefit and optimal patient care.
Master's Students
Doctoral Students
Graduate Degrees Awarded


Research Centres

The Centre for Drug Research and Development (CDRD) is located in our building. CDRD is an independent, non-profit organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. The Faculty partners with CDRD to provide unique research and mentoring opportunities for MSc and PhD students. 

We are also home to several sophisticated research centres that specialize in the areas of human genome and exome sequencing, pharmacokinetic drug metabolism studies, and health outcomes research.

Research Facilities

Opened in 2012, the Pharmaceutical Sciences building at UBC is a state-of-the-art learning and research facility. The new building houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities are fitted with advanced technology to facilitate new modes of learning.

Measuring 246,000 square feet, it's an eye-catching addition to our campus, and has drawn attention and admiration from around the world—including 15 awards of excellence. 

Research Highlights

As a leading research faculty, we conduct groundbreaking research in the pharmaceutical sciences – all with the goal of addressing the pressing health needs of society and improving lives. Our research activities centre around four areas of focus:

  • Health Outcomes
  • Molecular & Systems Pharmacology
  • Nanomedicine
  • Pharmacy Education

Explore Research Themes

Research Supervisors in Faculty

Name Research Interests
Bandiera, Stelvio drug metabolism; drug toxicity; drug interactions; steroids; toxicology including environmental pollutants such as pesticides, PCBs, TCDD and dioxins; effects on animals, biochemical toxicology, , Hepatic drug metabolism and environmental toxicology, chemical and biochemical aspects of drug metabolism, medicinal chemistry, structure-activity relationship
Burt, Helen Mary Nanotechnology, non-sized drug carriers, nanoparticulte drug delivery
Cairns, Brian pain mechanisms, headache, temporomandibular disorders, sex-related differences, peripheral analgesics
Chang, Thomas Pharmacology, Nuclear Receptor, Drug-Metabolizing Enzymes, Cytochrome P450, Gene Expression, Gene Regulation
Collier, Abby Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics
Conklin, Annalijn healthy ageing, obesity prevention, diabetes management and evaluation, healthcare quality improvement, implementation science, gender and health equity, nutrition-related policy and outcomes
Coughtrie, Michael Drug metabolizing enzymes
De Vera, Mary examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.
Ensom, Mary Clinical Pharmacokinetics, Clinical Pharmacodynamics, Clinical Pharmacogenetics, Therapeutic Drug Monitoring
Frankel, Adam family of human enzymes called protein arginine N-methyltransferases (PRMTs), which transfer methyl groups from S-adenosyl-L-methionine to arginine residues within proteins; contribution of PRMT activities to human diseases such as hormone-dependent cancers, inflammation, and cardiovascular disease
Giaever, Guri Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation
Grierson, David Chemistry, disease, biochemistry
Hafeli, Urs Radiopharmaceuticals, Radioimmunotherapy, Magnetic Targeting, Targeted Drug Delivery, Novel polymers, Nanoparticles, Microspheres, Microneedles, Bioconjugates
Harrison, Mark measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered
Jarvis-Selinger, Sandra Ann Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology
Kumar, Ujendra Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs
Lalji, Fawziah population and public health of communicable diseases; effectiveness and cost-effectiveness of new therapies in individuals with tuberculosis and immunization; pharmacoepidemiological evaluations; building a cost-effectiveness model for foreign born patients who have been exposed to LTBI, epidemiology of herpes zoster infections in BC, risk of zoster following immunosuppressive conditions and/or medications, epidemiology of community-acquired Clostridium difficile infections, meta-analysis on antibiotics used for C. difficile treatment, and adverse event reporting of influenza immunizations by pharmacists
Li, Shyh-dar drug delivery, pharmaceutics, nanomedicine, biopharmaceutics
Loewen, Peter atrial fibrillation, stroke prevention therapy, pharmacy practice, knowledge translation of evidence to patient care, patient education, shared decision-making, clinical prediction rules, prediction of stroke and bleeding in atrial fibrillation patients, patient decision aids, adherence to medication, patient complexiometry, healthcare communication technologies, use of mobile technology for clinical decision-making, hospital pharmacy practice, quality of care, quality drug therapy
Lynd, Larry health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases
MacLeod, Kathleen Cardiovascular complications, diabetes
McCormack, James Knowledge translation and evidence-based practice
Nislow, Corey genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing
O'Shea, Paul Multiparametric analysis of molecular biomarkers; towards a systems analysis of disease; Defining the rules of intermolecular associations in complex environments; The activities of biological membranes, visualized using spectroscopy and imaging
Rodrigues, Brian Cardiovascular metabolism, Diabetes, Endothelial cell - cardiomyocyte crosstalk


Graduate Student Profiles

Jonathon Campbell

Doctor of Philosophy in Pharmaceutical Sciences (PhD)
Building a cost-effective model for tuberculosis screening

Alumni on Success

Swamy Yeleswaram

Doctor of Philosophy in Pharmaceutical Sciences (PhD) [1992]
Job Title
Incyte Corporation

Gary Lopaschuk

Doctor of Philosophy in Pharmaceutical Sciences (PhD) [1983]
Job Title
University of Alberta

Recent Thesis Submissions